Cheryl Katavich, PA
Physician Assistant · Ashtabula, OHNPI 1295089266
Payments from drug & device makers
Across 76 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$376
- Corcept Therapeutics$244
- Amgen$169
- Novo Nordisk$153
- Xeris Pharmaceuticals, Inc.$146
- Lilly USA, LLC$81
- plus $382 from 15 others
What the payments were for
- Food & beverage$1,550100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $376 |
| Corcept Therapeutics | 12 | $244 |
| Amgen | 9 | $169 |
| Novo Nordisk | 9 | $153 |
| Xeris Pharmaceuticals, Inc. | 7 | $146 |
| Lilly USA, LLC | 4 | $81 |
| Ascendis Pharma Endocrinology Inc | 2 | $50 |
| Dexcom, Inc. | 2 | $44 |
| Neurocrine Biosciences, Inc. | 1 | $36 |
| AbbVie | 2 | $36 |
| Insulet Corporation | 2 | $27 |
| GRT US Holding, Inc. | 1 | $27 |
| Alk-abello, Inc | 1 | $24 |
| Antares Pharma, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $20 |
| Rayner Intraocular Lenses Limited | 1 | $19 |
| RGH Enterprises LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
How this compares
$1,550 in reported general payments places this provider in the 80th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 19 | $3,681 |
| Ipratropium Bromide | 81 | $2,036 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 29 | $1,402 |
| Famotidine | 157 | $1,340 |
| Fluticasone Propionate | 120 | $1,188 |
| Omeprazole | 76 | $513 |
| Cromolyn Sodium | 22 | $412 |
| Prednisolone Acetate | 11 | $379 |
| CefuroximeCefuroxime Axetil | 12 | $122 |
| Montelukast Sodium | 18 | $111 |
| Pantoprazole Sodium | 15 | $99 |
| Methylprednisolone | 14 | $80 |
| Azithromycin | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Ashtabula
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
- Jessica RhominskiCanal Winchester$78K
- Alan OdonnellCincinnati$71K
- Brook GramBeloit$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.